KRS 304.17A-137: Repealed, 2002.
Where this section sits in the code
Catchline at repeal: Coverage for prescribed cancer drugs not approved by the Federal
Food and Drug Administration for cancer treatment -- Review panel for off -label
uses.
Collected 2026-09-05T20:57:46Z. Source file · JSON